Fortis Healthcare Ltd. · NSE:FORTIS
Fortis Healthcare — Q1 FY2012 Earnings Presentation
18 slides from Fortis Healthcare's earnings presentation, August 2011
Slide 1: Fortis Healthcare Investor Presentation – Q1 FY2012
August 2011 Fortis Healthcare Investor Presentation – Q1 FY2012
Slide 2: Safe Harbor
Safe Harbor This presentation may not be copied, published, distributed or transmitted. The presentation has been prepared solely by the company. Any reference in this presentation to “Fortis Healthcare Limited” shall mean, collectively, the Company and its subsidiaries. This presentation has been p
Slide 3: Discussion Points
Discussion Points Highlights for the quarter Snapshot – Financial and Operational Performance Hospital wise performance Update on projects 3
Slide 4: Highlights for the quarter
Highlights for the quarter Key Highlights : Acquired strategic stake in Super Religare Laboratories (SRL) in line with our strategy to venture into new healthcare services verticals and integrate under one umbrella to drive synergies, improve quality and enhance reach The Company completed a decade
Slide 5: Highlights for the quarter…
Highlights for the quarter… Ground breaking ceremony for the Oncology Block at Fortis Mohali was held during the quarter. Once completed, the block would have 75 beds including ~30 ICU beds and 15 day-care beds The Company launched an initiative christened ‘Medex Transformers’, in order to foster me
Slide 6: Deep pan India presence
Deep pan India presence Operational Total Capacity No. of Hospitals Beds Category wise Presence across Owned 4,646 2,931 21 - 16 States Managed 1,796 1,010 28 - 34 Cities Projects 3,295 - 13 Grand Total 9,737 3,941 62 Region wise North 4,568 2,067 29 South 2,219 663 13 West 1,870 725 8 East 940 356
Slide 7: Snapshot – Financial Performance
Snapshot – Financial Performance Rs. in Cr. +43% +39% 600 573 Q1FY 12 – Consolidated Operating Revenue - Rs. 483 Cr 43% 483 500 Operating EBITDA* - Rs. 62 Cr 27% 413 Net Profit - Rs. 14 Cr 400 338 Statutory Q1FY11 Q1FY12* Occupancy 76% 70% 300 ARPOB (Annualized - Rs. 83 87 Lacs) ALOS (Days) 4.1 3.9
Slide 8: Financial Highlights of the quarter
Financial Highlights of the quarter Hospital Business Hospital network revenue at Rs 511 Cr. This includes revenue from International Patients - Rs 31.4 Cr (+51% q-o-q) (6.4% of hospital network revenue). Newly commissioned hospitals performed well and clocked revenue of ~Rs 27 Cr which includes For
Slide 9: Hospital wise Revenue & Operating margins – Q1FY12
Hospital wise Revenue & Operating margins – Q1FY12 Rs Cr. 21% 36% 25% 90 5% 17% 16% 17% 79 80 14% 16% 75 70 62 60 52 50 45 39 36 18% 38 40 17% 31 31 32 28 30 26 22 22% 24% 27% 19 19 17 26% 20 15 26% 20% 23% 22% 14% 22% 24% 22% 15% 22% 21% 13% 10 26% 0 FEHI Mohali Noida Mulund B G Road Vasant Kunj Ja
Slide 10: Maturity-wise Performance – Q1FY12: Main Hospitals
Maturity--wise Performance – Q1FY12: Main Hospitals Maturity Average Average Revenue EBITDA Average Maturity EBITDA ARPOB (Rs Contribution Contribution Occupancy margin * Cr) 14% of operating beds aged 5 years and above contributes 5 Years and 24% to revenue Above 24% 33% 21.7% 79% 1.14 (Four hospit
Slide 11: Summary – Consolidated Profit and Loss – Q1FY12
Summary – Consolidated Profit and Loss – Q1FY12 Q1FY12 Q1FY11 Hospital Diagnostics Total business Total Business Particulars Growth (%) (Rs Cr.) (Rs Cr.) (Rs Cr.) (Rs Cr.) Operating Revenue 421.2 62 483.2 337.9 43% Direct Costs 111.7 19.5 131.3 93.5 40% Employee Costs 78.9 13.0 91.9 62.7 47% Other C
Slide 12: Hospital Business: Base Operations
Hospital Business: Base Operations Q1FY12 Q1FY11 Particulars % % Growth (%) (Rs Cr.) (Rs Cr.) Operating Revenue 421.2 100% 337.9 100% 25% Direct Costs 111.7 27% 93.5 28% 19% Employee Costs 78.9 19% 62.7 19% 26% Other Costs 177.7 42% 133.1 39% 34% Operating EBITDA* 52.9 13% 48.5 14% 9% Other Income 1
Slide 13: No. of Procedures – Q1FY2012
No. of Procedures – Q1FY2012 Cardiac 13,988 Ortho 12,225 +14% 3,421 +29% 1,377 2,659 909 6,380 7,049 2047 1630 2,314 2,937 2,622 2,625 1029 1374 CTVS & Pediatrics PTCA CAG Others Knee Replacements THR & Others Neuro +16% Dialysis +47% 23055 1340 1400 15636 20000 1300 1152 1200 10000 1100 1000 0 Q1FY
Slide 14: Revenue Split
Revenue Split QIFY 11 QI FY12 OPD and Others 15% Cardiac Sciences 40% Multi- Specialties 23% Gastro 2% Oncology 4% Ortho 7% Neuro 5% Pulmo 1% Renal 3% Dependence on Cardiac Sciences has come down. At the same time, Orthopedics & Renal Sciences share has gone up at the back of Joint replacement and K
Slide 15: Upcoming Greenfield Hospitals in India
Upcoming Greenfield Hospitals in India Date of Estimate Area & Land No. Location Beds Commen d Capex Status Ownership cement (INR Cr) •Medical equipment is being installed 1 Kangra 100 37,000 sq. ft., B. Lease Q2 FY12 24 •Facility will be launched in Q2FY12 27,000 sq..ft., Public •Civil construction
Slide 16: Upcoming Greenfield Hospitals in India
Upcoming Greenfield Hospitals in India Date of Estimate No. Location Beds Area & Land Ownership Comme d Capex Status ncement (INR Cr) Peenya, 8 120 ~70,000 Sq ft; B. Lease FY13 18 •Construction work underway Bangalore •Cold Shell, being modified for a tertiary 9 Pune 350 252,000 sq.ft., B Lease FY13
Slide 17: Balance Sheet as at June 30, 2011
Balance Sheet as at June 30, 2011 Balance Sheet Rs Crore Shareholder’s Equity* 3,441 Foreign Currency Convertible Bonds (FCCB’s) 454 Debt 1,628 Total Capital Employed 5,522 Goodwill 1,906 Net Fixed Assets (including CWIP of Rs 344 Crore) 2,291 Investments - in Associates 8 - Deposits (including Inte
Slide 18: Thank You
Thank You... ‘ 42 Fortis